<DOC>
	<DOCNO>NCT02801032</DOCNO>
	<brief_summary>In double blind placebo-controlled cross-over study effect tadalafil blood flow velocity large artery brain , cortical brain oxygenation , peripheral endothelial function , endothelial biomarkers test patient lacunar stroke caused cerebral small vessel disease .</brief_summary>
	<brief_title>Effect Tadalafil Cerebral Large Arteries Stroke</brief_title>
	<detailed_description>Stroke frequently cause death decreased function everyday life , disease great human economic impact . Cerebral small vessel disease ( SVD ) underlie cause 25 % ischemic cerebral stroke lead vascular cognitive impairment ( VCI ) , disability case vascular dementia ( VaD ) . It well know cerebral blood flow ( CBF ) reduce VCI . To able improve blood flow vasculature white gray matter therefore desirable slow pathology VCI . The nitric oxide-cGMP vasodilator pathway show impaired endothelial dysfunction see SVD.This study target well-established mechanism action use compound selectively inhibit breakdown cGMP , PDE5 inhibitor tadalafil . The overall hypothesis chronic PDE5 inhibition tadalafil lessen severity progression vascular brain lesion via augmentation cerebral blood flow deep brain area . The specific primary hypothesis current project PDE5 inhibition single dose tadalafil ( Cialis® ) , contrast placebo , temporarily change blood flow large blood vessel brain change cortical brain oxygenation patient cerebral small vessel disease measure Transcranial Doppler near-infrared spectroscopy ( NIRS ) . The secondary hypothesis tadalafil improve peripheral endothelial function measure improved blood vessel response finger brief occlusion arm 's blood supply measure EndoPAT2000 . In addition change endothelial function biomarkers blood single dose tadalafil , change consistent measure peripheral central blood vessel function . In regulation cerebral artery flow neuronal signal nitric oxide ( NO ) cGMP act key molecule . In animal model , selective inhibitor cGMP degrade PDE5 , sildenafil tadalafil , report improve associate symptom endothelial dysfunction stroke recovery . Pre-clinical study support CBF-enhancing action PDE5 inhibitor cerebrovascular disease human study date limit sildenafil specifically address effect CBF people SVD . Tadalafil ( Cialis® ; Eli Lilly ) widely prescribe erectile dysfunction men . It also register regular daily use dose 40 mg pulmonary hypertension 5 mg benign prostatic hyperplasia . The side effect tadalafil well-known medicine usually well tolerate . Tadalafil choose PDE5 inhibitor ( sildenafil , Viagra® ) due 's potency , plasma half-life , selectivity PDE5 , document brain penetration .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Cerebral Small Vessel Diseases</mesh_term>
	<mesh_term>Stroke , Lacunar</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>1 . Radiological evidence cerebral small vessel disease define : MRI evidence lacunar infarct ( ) ( ≤ 1.5 cm maximum diameter ) and/or confluent deep white matter leukoaraiosis ( ≥ grade 2 Fazekas scale ) . 2 . Clinical evidence cerebral small vessel disease : 1. lacunar stroke syndrome symptom last &gt; 24 hour occur least 5 month previously ; OR 2. transient ischemic attack ( TIA ) last &lt; 24 hour limb weakness , hemisensory loss dysarthria least 5 month previously AND MR DWI perform acutely show lacunar infarction , OR MRI perform within ten day TIA , lacunar infarction anatomically appropriate position demonstrate subsequent MRI . 3 . Age ≥ 50 year . 4 . Imaging carotid artery Doppler ultrasound , CT angiography , MR angiography previous 12 month demonstrate &lt; 70 % stenosis internal carotid artery . 1 . Known diagnosis dementia 2 . Pregnancy nurse 3 . Cortical infarction ( &gt; 1.5 cm maximum diameter ) 4 . Systolic BP &lt; 90 and/or diastolic BP &lt; 50 5. eGFR &lt; 30 ml/min/1,73m2 6 . Severe hepatic impairment 7 . History Lactose intolerance 8 . Concomitant use PDE5 inhibitor e.g . sildenafil , tadalafil , vardenafil 9 . Patients receive nicorandil nitrate e.g . isosorbide mononitrate , isosorbide dinitrate , glyceryl trinitrate 10 . Body weight &gt; 130kg 11 . Uncontrolled cardiac failure 12 . Persistent paroxysmal atrial fibrillation 13 . History `` sick sinus syndrome '' supraventricular cardiac conduction condition sinoatrial atrioventricular block 14 . Uncontrolled COPD 15 . Stroke TIA within last 5 month . 16 . MRI tolerate contraindicate : MRI exclusion criterion : Participant cardiac pacemaker ; recent surgery ; vascular clip ; metal implant joint replacement compatible MRI ; metal fragment eye ; ever work lathe ; shrapnel war injury ; possibility pregnancy 17 . Known monogenic cause stroke i.e . CADASIL 18 . The patient wish know important result MRI 19 . Unable provide inform consent 20 . Not possible localise a. cerebri medium bilaterally inclusion day Transcranial Doppler</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>